Full name
PHARMA ODYN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20 - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.9 - Retail sale via intermediaries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,7 | 0,3 | 0,2 | -19,1 |
Gross profit (loss) | -1,2 | -5,6 | 0,2 | 104,1 |
EBITDA | -0 | -2 | 1,4 | 171,1 |
Short time liabilities | 3,3 | 2,9 | 3,3 | 14,7 |
Other operating costs | 0,4 | 2,8 | 1,4 | -49,7 |
Equity capital | -13,1 | -18,7 | -18,5 | 1,2 |
Operating profit (EBIT) | -0,5 | -2,4 | 1,3 | 153,5 |
Assets | 8,3 | 5 | 5,5 | 10,7 |
Net profit (loss) | -1,2 | -5,6 | 0,2 | 104,1 |
Cash | 0,1 | 0,1 | 0,1 | 0,8 |
Liabilities and provisions for liabilities | 21,4 | 23,7 | 24 | 1,3 |
Net income from sale | 17,7 | 20,4 | 21,4 | 4,8 |
Working assets | 3,8 | 3,4 | 4 | 16,7 |
Other income costs | 0,6 | 0,2 | 2,5 | 1529,2 |
Depreciation | 0,5 | 0,4 | 0,1 | -68,4 |
% | % | % | p.p. | |
Profitability of capital | 9,5 | 30 | -1,2 | -31,2 |
Equity capital to total assets | -157,1 | -373,8 | -333,6 | 40,2 |
Gross profit margin | -7 | -27,5 | 1,1 | 28,6 |
EBITDA Margin | -0,2 | -9,7 | 6,6 | 16,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 69 | 52 | 57 | 5 |
Current financial liquidity indicator | 1.1335573196411133 | 1.1632449626922607 | 1.1834691762924194 | 0 |
Net dept to EBITDA | -646.0172119140625 | -9.362483978271484 | 13.918668746948242 | 23,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane